Literature DB >> 8005587

Tight linkage of pyruvate kinase (PKLR) and glucocerebrosidase (GBA) genes.

D Glenn1, T Gelbart, E Beutler.   

Abstract

Two polymorphisms, one in the liver-type pyruvate kinase gene (PKLR) and one in the glucocerebrosidase gene (GBA), both of which are on band q21 of chromosome 1, were found to be tightly linked. Each of three Gaucher disease mutations in 112 chromosomes studied was associated with a unique haplotype. With a conservative assumption about the length of time that the Gaucher disease mutation has been present in the Jewish population, we deduce that the genetic distance between these two loci is probably under 0.2 centimorgans. Four haplotypes are produced by these polymorphic loci, but two of these are relatively uncommon because the polymorphic sites are in linkage disequilibrium. Nonetheless these markers are potentially useful in the prenatal diagnosis of pyruvate kinase deficiency in families who have at least one affected child and may also be helpful in heterozygote detection in families with Gaucher disease where a specific mutation producing the disease in unknown.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005587     DOI: 10.1007/BF00201562

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

1.  Integration of gene maps: chromosome 1.

Authors:  A Collins; B J Keats; N Dracopoli; D C Shields; N E Morton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  Polymorphisms in the human glucocerebrosidase gene.

Authors:  E Beutler; C West; T Gelbart
Journal:  Genomics       Date:  1992-04       Impact factor: 5.736

3.  Linkage of the PvuII polymorphism with the common Jewish mutation for Gaucher disease.

Authors:  A Zimran; T Gelbart; E Beutler
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

4.  Restriction fragment length polymorphism analysis in healthy Japanese individuals and Japanese families with Gaucher disease.

Authors:  M Masuno; T Orii; K Sukegawa; T Taga
Journal:  Acta Paediatr Jpn       Date:  1989-04

5.  The human liver-type pyruvate kinase (PKL) gene is on chromosome 1 at band q21.

Authors:  H Satoh; K Tani; M C Yoshida; M Sasaki; S Miwa; H Fujii
Journal:  Cytogenet Cell Genet       Date:  1988

6.  Point mutations in the L-type pyruvate kinase gene of two children with hemolytic anemia caused by pyruvate kinase deficiency.

Authors:  B Neubauer; M Lakomek; H Winkler; M Parke; S Hofferbert; W Schröter
Journal:  Blood       Date:  1991-05-01       Impact factor: 22.113

7.  Analysis of pyruvate kinase-deficiency mutations that produce nonspherocytic hemolytic anemia.

Authors:  L Baronciani; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  Identical point mutations of the R-type pyruvate kinase (PK) cDNA found in unrelated PK variants associated with hereditary hemolytic anemia.

Authors:  H Kanno; H Fujii; A Hirono; M Omine; S Miwa
Journal:  Blood       Date:  1992-03-01       Impact factor: 22.113

9.  cDNA cloning of human R-type pyruvate kinase and identification of a single amino acid substitution (Thr384----Met) affecting enzymatic stability in a pyruvate kinase variant (PK Tokyo) associated with hereditary hemolytic anemia.

Authors:  H Kanno; H Fujii; A Hirono; S Miwa
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

  9 in total
  6 in total

1.  D409H/D409H genotype in Gaucher-like disease.

Authors:  E Uyama; M Uchino; H Ida; Y Eto; M Owada
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

2.  Characteristics of gene mutations among 32 unrelated Japanese Gaucher disease patients: absence of the common Jewish 84GG and 1226G mutations.

Authors:  H Ida; K Iwasawa; H Kawame; O M Rennert; K Maekawa; Y Eto
Journal:  Hum Genet       Date:  1995-06       Impact factor: 4.132

3.  Molecular study of pyruvate kinase deficient patients with hereditary nonspherocytic hemolytic anemia.

Authors:  L Baronciani; E Beutler
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

4.  Age estimate of the N370S mutation causing Gaucher disease in Ashkenazi Jews and European populations: A reappraisal of haplotype data.

Authors:  R Colombo
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

5.  Sequence variability of a human pseudogene.

Authors:  R Martínez-Arias; F Calafell; E Mateu; D Comas; A Andrés; J Bertranpetit
Journal:  Genome Res       Date:  2001-06       Impact factor: 9.043

6.  Glucocerebrosidase mutations in Gaucher disease.

Authors:  E Beutler; A Demina; T Gelbart
Journal:  Mol Med       Date:  1994-11       Impact factor: 6.354

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.